Scarica l'app Stockscreener
1.26
1.61%
0.02
Dopo l'orario di chiusura:
1.26
Precedente Chiudi:
$1.24
Aprire:
$1.26
Volume 24 ore:
33,685
Relative Volume:
0.34
Capitalizzazione di mercato:
$36.34M
Reddito:
$48.20M
Utile/perdita netta:
$-35.05M
Rapporto P/E:
-0.8039
EPS:
-1.5673
Flusso di cassa netto:
$-13.02M
1 W Prestazione:
+13.51%
1M Prestazione:
-33.33%
6M Prestazione:
-33.33%
1 anno Prestazione:
-41.94%
Intervallo 1D:
$1.2304
$1.28
Intervallo di 1 settimana:
$1.098
$1.31
Portata 52W:
$1.01
$4.35
Celularity Inc Stock (CELU) Company Profile
Nome
Celularity Inc
Settore
Industria
Telefono
(908) 768-2170
Indirizzo
170 PARK AVE, FLORHAM PARK
Confronta CELU con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CELU
Celularity Inc
|
1.26 | 35.76M | 48.20M | -35.05M | -13.02M | -1.5673 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Celularity Inc Stock (CELU) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-01-30 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2022-12-22 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-06-22 | Iniziato | H.C. Wainwright | Buy |
| 2022-04-06 | Downgrade | Truist | Buy → Hold |
| 2022-01-28 | Iniziato | Oppenheimer | Outperform |
| 2021-11-24 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Celularity Inc Borsa (CELU) Ultime notizie
Why Celularity Inc. Equity Warrant stock could see breakout soonJuly 2025 Intraday Action & Technical Confirmation Trade Alerts - ulpravda.ru
Will Celularity Inc. stock split attract more investors2025 Trading Volume Trends & Stock Portfolio Risk Management - ulpravda.ru
Is Celularity Inc. Equity Warrant stock a smart buy before Fed meetingInflation Watch & Proven Capital Preservation Tips - ulpravda.ru
Will Celularity Inc. stock outperform tech sector in 2025Stock Price Divergence & Fast Growing Trading Plans - ulpravda.ru
Does Shoora Designs Limited Stock Fit a LongTerm Value StrategyMarket Rumors and News & High Return Stock Ideas - earlytimes.in
Sheppard Mullin Advised Vanterra Ventures, Silo Pharma, Celularity And Others In Recent Deals - Mondaq
Celularity files for offering of up to 14.1 million shares of class A common stock - MarketScreener
Celularity Files for Sale of 14.1 Million Class A Shares - marketscreener.com
Celularity (NASDAQ:CELU) Trading Down 10.4% – Here’s Why - Defense World
Celularity's Biovance, Biovance 3L To Remain Eligible For Med. Coverage Under Withdrawn LCDs - Nasdaq
Aug Outlook: What Wall Street predicts for Celularity Inc Equity Warrant stock price2025 Breakouts & Breakdowns & Consistent Return Strategy Ideas - moha.gov.vn
Celularity secures new financing to support strategic shift - MSN
Celularity CEO Comments on Centers for Medicare & Medicaid Services' Withdrawal of Skin Substitute Local Coverage Determinations - Investing News Network
Celularity stock drops after CMS withdraws skin substitute LCDs By Investing.com - Investing.com Nigeria
Celularity stock drops after CMS withdraws skin substitute LCDs - Investing.com
Celularity Inc. Comments on CMS Withdrawal of Skin Substitute Coverage Determinations - Quiver Quantitative
Celularity CEO Comments on Centers for Medicare & Medicaid Services’ Withdrawal of Skin Substitute Local Coverage Determinations - The Manila Times
Medicare rewrites rules for wound skin grafts; Celularity says it’s ready - Stock Titan
Celularity Secures New Financing To Support Strategic Shift - The Globe and Mail
Celularity Signs Multiple Material Agreements - TradingView — Track All Markets
Celularity Closes Financing Transactions - citybiz
Celularity secures $10 million financing from DoubleLine co-founder By Investing.com - Investing.com Nigeria
Celularity Announces Closing of Financing Transactions - Investing News Network
Celularity secures $10 million financing from DoubleLine co-founder - Investing.com India
Longevity-focused biotech Celularity raises $10M for aging research - Stock Titan
Celularity announces up to $12M of capital from Philip Barach - MSN
Why Celularity Inc. Equity Warrant stock could rally in 20252025 Price Action Summary & Verified Swing Trading Watchlist - DonanımHaber
Celularity Shareholders Reject Expansion of Equity Incentive Plan - The Globe and Mail
Can Celularity Inc. stock deliver surprise earnings beatJuly 2025 Earnings & AI Enhanced Trading Alerts - Улправда
Why Celularity Inc. Equity Warrant stock could benefit from AI revolution2025 Stock Rankings & Safe Investment Capital Preservation Plans - Улправда
Celularity raises $12m to sharpen longevity strategy - Longevity.Technology
What Wall Street predicts for Celularity Inc. Equity Warrant stock priceAnalyst Downgrade & Real-Time Sentiment Analysis - DonanımHaber
Is Celularity Inc. Equity Warrant stock dividend yield sustainable2025 Market Outlook & AI Based Buy and Sell Signals - DonanımHaber
Why Celularity Inc. stock is favored by top institutionsStop Loss & Weekly Watchlist for Hot Stocks - DonanımHaber
Will Celularity Inc. Equity Warrant stock outperform Dow Jones indexPortfolio Risk Report & Risk Controlled Swing Alerts - DonanımHaber
Celularity Reaches Binding Term Sheets on Financing Transactions to Support Its Strategic Vision - The Manila Times
Performance Recap: Will Celularity Inc. stock outperform tech sector in 2025Weekly Trade Summary & Growth Focused Stock Reports - moha.gov.vn
Why Celularity Inc. stock is favored by pension funds2025 Risk Factors & Precise Buy Zone Identification - Улправда
Celularity secures up to $12 million in financing for longevity focus - Investing.com Australia
Celularity Inc. Secures Up to $12 Million in Financing to Advance Strategic Priorities in Longevity and Human Performance - Quiver Quantitative
DoubleLine co-founder backs up to $12M funding plan for longevity - Stock Titan
Celularity Inc.'s (NASDAQ:CELU) 25% Dip In Price Shows Sentiment Is Matching Revenues - 富途牛牛
Celularity Inc. announced that it expects to receive $12 million in funding - marketscreener.com
There Is A Reason Celularity Inc.'s (NASDAQ:CELU) Price Is Undemanding - simplywall.st
Celularity Inc Azioni (CELU) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.80%
4.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):